<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr113-0300060519845488">
 <label>113</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rudenko</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Desheva</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Korovkin</surname>
    <given-names>S</given-names>
   </name>
  </person-group>, 
  <etal>et al</etal>
  <article-title>Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).</article-title>
  <source>Influenza Other Respir Viruses</source>
  <year>2008</year>; 
  <volume>2</volume>: 
  <fpage>203</fpage>–
  <lpage>209</lpage>. DOI: 10.1111/j.1750-2659.2008.00064.x.
  <pub-id pub-id-type="pmid">19453396</pub-id>
 </mixed-citation>
</ref>
